MedTrace Logo

Transcranial Magnetic Stimulation (TMS) Treatment for Alcohol Use Disorder

NCT03969251 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-10-27

No results posted yet for this study

Summary

This is a pilot study designed to evaluate the efficacy of High Frequency (HF) repetitive transcranial magnetic stimulation (rTMS) of the left dorsolateral prefrontal cortex (L-DLPFC) at improving cognitive flexibility in recently detoxified individuals with alcohol use disorder (AUD) compared to placebo (Sham rTMS). The total number of subjects requested to be randomized is 20. The investigator will need to screen about 40 subjects to have 20 subjects started on rTMS session at a ratio of 2 screens/1 subject randomized.

Conditions

  • Alcoholism

Interventions

DEVICE

Transcranial Magnetic Stimulation (rTMS)

active high frequency repetitive TMS of left Dorsolateral Prefrontal Cortex

DEVICE

Sham (SS)

repetitive sham rTMS

Sponsors & Collaborators

  • Nassima Ait-Daoud Tiouririne

    lead OTHER

Principal Investigators

  • Nassima Ait-Daoud TIouririne, M.D. · University of Virginia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2021-03-31
Completion
2021-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03969251 on ClinicalTrials.gov